Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 38

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 38
---
 named
executive officers and the compensation philosophy, policies and practices described in this proxy statement.

In accordance with the rules of
the SEC, the following resolution, commonly known as a “say-on-pay” vote, is being submitted for a stockholder vote at the
Annual Meeting:

RESOLVED, on a non-binding,
advisory basis only, that the compensation paid to the named executive officers of Lunai Bioworks, Inc., as disclosed pursuant to the
compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and the related material disclosed
in this proxy statement, is hereby APPROVED.

Required Vote

The affirmative vote of one-third
of the votes cast in person or represented by proxy at the meeting and entitled to vote for this proposal is required to approve this
proposal, on an advisory basis.

OUR BOARD RECOMMENDS A VOTE TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.

<div align='center'>24

REPORT OF THE AUDIT COMMITTEE</div>

The Audit Committee reviewed and
discussed the audited financial statements for the year ended June 30, 2025 with management, and with Sadler, the Company’s independent
registered public accounting firm. Further, the Audit Committee also discussed with Sadler the matters required to be discussed by the
applicable requirements of the Public Company Accounting Oversight Board (the “”) and the SEC. The Audit Committee
reviewed permitted services under rules of the SEC as currently in effect and discussed with Sadler its independence from management and
the Company, including the matters in the written disclosures and the letter from Sadler required by the applicable requirements of the
PCAOB regarding the independent accountant’s communications with the Audit Committee concerning independence.

Based on its review of the financial
statements and the aforementioned discussions, the Audit Committee recommended to the Board of Directors that the audited financial statements
be included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025 for filing with the SEC.

THE AUDIT COMMITTEE

James McNulty (Chair)

Douglas Calder

Dr. Mark Collins

<div align='center'>PROPOSAL 3:
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT